NCT03531463

Brief Summary

The Nordic DeltaCon Trial is a prospective, single-blinded, randomized, controlled, multi-center and multi-national trial comparing reverse prosthesis and non-operative treatment in displaced proximal humerus fractures, in the elderly patients aged 65 to 85 years with displaced OTA/AO group B2 or C2 fractures (According to the new 2018 revision: AO/OTA (Orthopaedic Trauma Association) group 11-B1.1, 11-B1.2 and 11-C1.1, 11-C3.1. )

Trial Health

78
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
154

participants targeted

Target at P75+ for not_applicable

Timeline
31mo left

Started Oct 2018

Longer than P75 for not_applicable

Geographic Reach
3 countries

3 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Oct 2018Dec 2028

First Submitted

Initial submission to the registry

April 27, 2018

Completed
24 days until next milestone

First Posted

Study publicly available on registry

May 21, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

October 1, 2018

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2023

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2028

Expected
Last Updated

January 6, 2026

Status Verified

December 1, 2025

Enrollment Period

5.2 years

First QC Date

April 27, 2018

Last Update Submit

December 31, 2025

Conditions

Keywords

DisplacedNon-Operative treatmentReversed Total Shoulder Prosthesis

Outcome Measures

Primary Outcomes (1)

  • Quick-DASH

    The short form of Disabilities of the arm, shoulder and hand

    From enrollment to 5 years follow-up. Scale 1-4 points (Total point x answers given) x25. Lowest point best

Secondary Outcomes (6)

  • Oxford Shoulder Score

    From enrollment to 5 years follow-up. Scale 0 - 48, lowest score best.

  • 15 D Quality of Life

    From enrollemtn to 5 years follow-up. 15 questions, 5 levels, scale 0.000 - 1.000. Highest number best.

  • Constant score (CS)

    From enrollment to 5 years follow-up. Scale 0- 100 points. Highest best if only actual shoulder is scored..

  • VAS pain

    From enrollement to 5 eyars follow-up. Scale 0-15 points, best equal zero points

  • Radiographic + Computer Tomography scan (CT)

    From enrollemnt to 5 years follow-up for plain radiographs. CT at enrollement and at 2 years.

  • +1 more secondary outcomes

Study Arms (2)

Operative treatment

ACTIVE COMPARATOR

Operative treatment of the displaced proximal humeral fracture with a reversed total shoulder prothesis (Delta prosthesis) using a stadardized deltopectoral approach, bone block grafting and thread cerclages of the tubercles. Rehabilitation with standardized physiotherapy guideline and self exercise protocol

Procedure: Operative treatment with Reversed Total Shoulder Prosthesis

Non-Operative treatment

NO INTERVENTION

Rehabilitation with standardized physiotherapy guideline and self exercise protocol

Interventions

The standardized approach is the delto-pectoral to minimize any damage of the deltoid muscle. A cemented monoblock humeral stem will be implanted. Braided polyester suture-cerclages engaging the insertion of the subscapular and infraspinatus tendons enforced by a bonegraft or a "horseshoe-graft" from the humeral head will be used

Operative treatment

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Low energy AO/OTA group 11-B1.1, 11-B1.2 and 11-C1.1, 11-C3.1. Both B and C type includes subgroups: Displaced \[2\], Impacted \[3\] or Non impacted \[4\] from the universal modifiers list.

You may not qualify if:

  • Radiographic Mal-inclination Less than; varus 30°or valgus 45° Less than 50% contact between head fragment and meta-/diaphysis Head split fractures with more than 10% of the articular surface in the main head fragment.
  • Head split fractures (group 11-C3.2 and 11-C3.3) with more than 10% of the articular surface in the main head fragment.
  • Dislocation or fracture-dislocation of the gleno-humeral joint Pathological fracture
  • General
  • Refuse to participate
  • Age under 65 years of age, or over 85 years of age
  • Serious poly-trauma or additional surgery
  • Non-independent, drug/alcohol abuse or institutionalized (low co-operation)
  • Contra-indications for surgery
  • Does not understand written and spoken guidance in local languages
  • Previous fracture with symptomatic sequelae in either shoulder
  • Patients living outside the hospital's catchment area

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Aarhus University Hospital, Division of Orthopaedics

Aarhus, Denmark

Location

Tampere University Hospital, Division of Orthopaedics

Tampere, Finland

Location

Oslo University Hospital, Division of Orthopaedics

Oslo, Norway

Location

Related Publications (1)

  • Launonen AP, Fjalestad T, Laitinen MK, Lahdeoja T, Ekholm C, Wagle T, Mattila VM; NITEP-group. Nordic Innovative Trials to Evaluate osteoPorotic Fractures (NITEP) Collaboration: The Nordic DeltaCon Trial protocol-non-operative treatment versus reversed total shoulder arthroplasty in patients 65 years of age and older with a displaced proximal humerus fracture: a prospective, randomised controlled trial. BMJ Open. 2019 Jan 29;9(1):e024916. doi: 10.1136/bmjopen-2018-024916.

    PMID: 30700485BACKGROUND

Related Links

MeSH Terms

Conditions

Shoulder Fractures

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesShoulder Injuries

Study Officials

  • Ville Mattila, Professor

    Professor in orthopedics and traumatology, Tampere University Chief of musculoskeletal department, Tampere University Hospital Visiting professor, Karolinska Institute, Stockholm

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Physiotheraphists specialized in shoulder injuries collect all data and perform all tests / interviews of patients during FU at 3 months, 1-2-5 years. Blinded for the allocation / treatment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled single-blinded trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator Tore Fjalestad, MD. Ph.D. Consultant Orthopaedic Surgeon, Mail: torfja@online.no / tofjal@ous-hf.no , Ph:+4797013389

Study Record Dates

First Submitted

April 27, 2018

First Posted

May 21, 2018

Study Start

October 1, 2018

Primary Completion

December 10, 2023

Study Completion (Estimated)

December 10, 2028

Last Updated

January 6, 2026

Record last verified: 2025-12

Locations